Catalyst Wire Dossier Catalyst Wire Dossier

BIBN 4096 BS

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for BIBN 4096 BS, covering 2014-07-23 to 2014-07-29. Get the full timeline:

Most recent: Clinical Trial Update: Study to Determine Tolerability After Intravenous Administration of BIBN 4096 BS in Healthy Male and Female Volunteers [Phase 1]

See pricing